Table 2.
Mean OOP, Third-Party, and Total PrEP Medication Payments With Complete Payment Data, by Age, Sex, Region, and Payer Type, 2018
| Variable | Prescriptions, n | Mean OOP Payment per 30 Tablets (SD), $ |
Mean Third-Party Payment per 30 Tablets (SD), $ |
Mean Total Payment per 30 Tablets (SD), $ |
|---|---|---|---|---|
| All prescriptions | 759 409 | 94 (271) | 1544 (370) | 1638 (255) |
| Age | ||||
| 16-17 y | 711 | 37 (187) | 1596 (247) | 1632 (187) |
| 18-24 y | 69 132 | 94 (277) | 1531 (371) | 1625 (252) |
| 25-34 y | 292 770 | 99 (281) | 1532 (373) | 1631 (250) |
| 35-44 y | 192 584 | 92 (265) | 1551 (360) | 1643 (250) |
| 45-54 y | 131 441 | 89 (260) | 1558 (365) | 1647 (260) |
| 55-64 y | 62 144 | 86 (256) | 1565 (373) | 1651 (272) |
| ≥65 y | 10 627 | 117 (263) | 1513 (451) | 1631 (341) |
| Sex | ||||
| Male | 723 483 | 95 (270) | 1543 (370) | 1639 (256) |
| Female | 35 653 | 72 (275) | 1561 (356) | 1633 (247) |
| Unknown | 273 | 303 (667) | 1352 (692) | 1656 (161) |
| Region | ||||
| Northeast | 225 846 | 82 (255) | 1570 (327) | 1651 (204) |
| Midwest | 94 861 | 121 (316) | 1521 (418) | 1642 (286) |
| South | 218 768 | 111 (286) | 1540 (360) | 1651 (217) |
| West | 212 130 | 79 (244) | 1530 (395) | 1609 (317) |
| Unknown | 7804 | 84 (304) | 1562 (430) | 1646 (242) |
| Third-party payer | ||||
| Commercial | 594 871 | 107 (272) | 1549 (334) | 1655 (181) |
| Medicaid/CHIP | 91 305 | 3 (45) | 1583 (289) | 1586 (285) |
| Medicare | 18 510 | 80 (201) | 1583 (320) | 1662 (184) |
| Gilead Sciences | ||||
| Medication assistance | 32 976 | 0 (27) | 1720 (46) | 1721 (37) |
| Copay assistance | 6595 | 31 (177) | 1272 (849) | 1303 (849) |
| Cash payment | 4619 | 1902 (268) | 0 | 1902 (268) |
| Other | 10 073 | 384 (749) | 387 (635) | 771 (808) |
| Unknown | 460 | 189 (544) | 760 (701) | 949 (715) |
CHIP = Children's Health Insurance Program; OOP =out-of-pocket; PrEP = preexposure prophylaxis.